ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
41 announcements with these filters
HealthCare Global Enterprises filed its Annual Secretarial Compliance Report for FY 2025-26. The auditor confirmed adherence to SEBI regulations with no adverse observations reported.
HCG delivered strong FY26 results with 15% revenue growth and margin expansion to 18.5%, driven by operational leverage and clinical excellence.
HealthCare Global Enterprises confirmed zero deviation in utilizing ₹424.68 Crore raised through its recent Rights Issue. The funds were deployed for debt repayment and acquisitions.
HealthCare Global reported FY26 revenues of ₹2,545.4 Crore, a 15% year-on-year increase. Adjusted EBITDA grew 19%, reflecting strong oncology network performance and improved capacity utilization.
HCG reported FY26 revenue of INR 25.4bn (up 15% YoY) and Adj. EBITDA of INR 4.7bn (up 19% YoY), driven by network productivity and operational leverage.
HealthCare Global Enterprises appointed Sanjeev Kumar as CFO and re-appointed Rajiv Maliwal as Independent Director. These leadership updates take effect from May 2026.
HealthCare Global Enterprises is divesting its entire stake in BACC Health Care for ₹37.64 Crore. The sale to Inviga Healthcare Fund I enables strategic cancer-care focus.
Healthcare Global Enterprises Ltd reported revenue from operations of ₹650.3 Cr (+11.5% YoY) and net profit of ₹4 Cr (-41.2% YoY) for Q4 FY26.
HealthCare Global approved FY2026 audited results and the ₹37.64 Crore divestment of its BACC subsidiary. The company also appointed a new CFO and Internal Auditor.
HealthCare Global launched a new 132-bed comprehensive cancer hospital in Hebbal, North Bengaluru. The facility introduces Karnataka's first MR-Linac technology for precision oncology.
Healthcare Global Enterprises Limited filed its monitoring agency report for the ₹424.68 Crore rights issue. Proceeds remain unutilized as of the March 2026 quarter end.